Burning Rock Biotech Limited (NASDAQ: BNR) AI-Powered Stock Analysis
See how Burning Rock Biotech Limited scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
BNR●NASDAQ
HealthcareMedical - Diagnostics & Research
$8.88
$0.09(1.003%)
U.S. Market opens in 13h 59m
Burning Rock Biotech Limited (NASDAQ: BNR) AI-Powered Stock Analysis
See how Burning Rock Biotech Limited scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerBurning Rock Biotech Limited (NASDAQ: BNR) Stock Overall Grade
Burning Rock Biotech Limited's grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Burning Rock Biotech Limited's overall NASDAQ stock rating.
Forecast
B+Score
73/100Financial Growth
CScore
40/100Fundamental Growth
DScore
30/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Burning Rock Biotech Limited (NASDAQ: BNR) AI-Powered Stock Analysis
On the NASDAQ, BNR demonstrates Normal performance with an overall Forecast Score of 73/100 (B+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (30/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NASDAQ: BNR) Component Analysis Explained
Understand the key factors behind each Burning Rock Biotech Limited (NASDAQ: BNR) stock grade, including financials, comparisons, and forecasts.